Atea Pharmaceuticals
Stock Forecast, Prediction & Price Target
Atea Pharmaceuticals Financial Estimates
Atea Pharmaceuticals Revenue Estimates
Atea Pharmaceuticals EBITDA Estimates
Atea Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $351.36M N/A | $0 -100% | $0 0% | Avg: $45.24M Low: $1.51M High: $96.63M avg. 0% | Avg: $109.35M Low: $65.18M High: $158.15M avg. 141.71% | Avg: $237.9M Low: $141.81M High: $344.07M avg. 117.55% | |
Net Income
% change YoY
| $121.19M N/A | $-115.90M -195.64% | $-135.95M -17.29% | Avg: $-250.98M Low: $-267.55M High: $-228.48M avg. -84.60% | Avg: $-252.61M Low: $-267.16M High: $-80.29M avg. -0.64% | Avg: $16.67M Low: $7.92M High: $26.35M avg. 106.60% | |
EBITDA
% change YoY
| $138.37M N/A | $-130.65M -194.41% | $-119.59M 8.46% | Avg: $28.65M Low: $956.56K High: $61.21M avg. 123.96% | Avg: $69.27M Low: $41.29M High: $100.18M avg. 141.71% | Avg: $150.70M Low: $89.83M High: $217.96M avg. 117.55% | |
EPS
% change YoY
| $1.46 N/A | -$1.39 -195.20% | -$1.63 -17.26% | Avg: -$2.97 Low: -$3.21 High: -$2.74 avg. -82.46% | Avg: -$2.03 Low: -$3.2 High: -$0.96 avg. 31.83% | Avg: $0.2 Low: $0.09 High: $0.32 avg. 109.86% | |
Operating Expenses
% change YoY
| $212.99M N/A | $130.65M -38.65% | $94.07M -27.99% | Avg: $32.34M Low: $1.07M High: $69.09M avg. -65.61% | Avg: $78.19M Low: $46.61M High: $113.08M avg. 141.71% | Avg: $170.11M Low: $101.40M High: $246.03M avg. 117.55% | |
FAQ
What is Atea Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 7.11% in 2025-2027.
We have gathered data from 2 analysts. Their low estimate is -267.55M, average is -250.98M and high is -228.48M.
What is Atea Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 86.42% in 2025-2027.
We have gathered data from 2 analysts. Their low revenue estimate is $1.51M, average is $45.24M and high is $96.63M.
What is Atea Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 19.74% in 2025-2027.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$3.21, average is -$2.97 and high is $-2.74.